We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
77 ELEKTRONIKA

Download Mobile App




Events

31 Jul 2024 - 02 Aug 2024
02 Aug 2024 - 04 Aug 2024
20 Aug 2024 - 22 Aug 2024

Flexible Device Enables Sweat Gland Stimulation and Simultaneous Biosensing

By HospiMedica International staff writers
Posted on 29 May 2024
Print article
Image: The device stimulates sweat production through drug delivery to the skin (Photo courtesy of KIST)
Image: The device stimulates sweat production through drug delivery to the skin (Photo courtesy of KIST)

Human sweat is rich in biomarkers that can be used to monitor a range of health conditions, from diabetes to genetic disorders. Many users prefer sweat sampling over blood collection because it is painless. However, one must engage in intense physical activity to produce enough sweat to extract sufficient nutrients or hormones from sweat for testing. This requirement is particularly challenging for those with limited mobility. Researchers have now developed a new type of sweat monitoring device that stimulates sweat production through drug delivery to the skin, eliminating the need for physical exertion.

The device was created through a collaboration between researchers at the Korea Institute of Science and Technology (KIST, Seoul, South Korea) and Northwestern University (Evanston, IL, USA). This innovative device applies a current to a drug-containing hydrogel, which then delivers the drugs directly to the sweat glands. The device is flexible, small, and soft, making it easy to attach to the skin. Sweat stimulated by the drug is channeled into microfluidic channels within the device and analyzed for biomarkers using integrated biosensors. This system facilitates the analysis of sweat biomarkers without the cumbersome need for hospital visits, reduces the risk of biomarker contamination during testing, and enhances the accuracy of the results. The device was tested on infants diagnosed with cystic fibrosis, measuring the chloride concentration in their sweat. The findings matched the accuracy of traditional sweat analysis methods used in hospitals, achieving over 98% accuracy.

Moreover, the stability of the device on the skin was verified by monitoring skin temperature and pH levels. Given that cystic fibrosis primarily manifests during infancy, continuous monitoring of disease progression and the infant's physical condition is crucial. This device enables easy monitoring at home, significantly reducing the psychological and physical burden on young patients and their caregivers. Beyond its immediate application, this device represents a significant advance in the field of non-invasive disease monitoring technology using sweat, applicable not only to infants but also to healthy adults. Additionally, the technology used for drug delivery through the skin could potentially enhance the effectiveness of localized drug treatments for skin conditions or wounds, thus speeding up the healing process.

"Through two years of collaborative research with Northwestern University, we have not only addressed the limitations of existing methods for inducing sweat but also achieved success in clinical research, bringing us one step closer to commercialization," said Dr. Kim Joohee from KIST.

Related Links:
KIST
Northwestern University

Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Gold Member
12-Channel ECG
CM1200B
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Hemoconcentrator
Hemocor HPH

Print article

Channels

Surgical Techniques

view channel
Image: Fixation screws for ligament to bone repair (Photo courtesy of 4D Medicine)

Novel Biomaterial Platform Opens Up New Possibilities for Implants and Devices

Resorbable biomaterials, crucial for implantable medical devices, have seen little innovation over decades. Materials like Polylactic Acid (PLA), Polycaprolactone (PCL), and Poly Lactic-co-Glycolic Acid... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: POCT offers cost-effective, accessible, and immediate diagnostic solutions (Photo courtesy of Flinders University)

POCT for Infectious Diseases Delivers Laboratory Equivalent Pathology Results

On-site pathology tests for infectious diseases in rural and remote locations can achieve the same level of reliability and accuracy as those conducted in hospital laboratories, a recent study suggests.... Read more

Business

view channel
Image: The Innovalve transseptal delivery system is designed to enable safe deployment of the Innovalve implant (Photo courtesy of Innovalve Bio)

Edwards Lifesciences Acquires Sheba Medical’s Innovalve Bio Medical

Edwards Lifesciences (Irvine, CA, USA), a leading company in medical innovations for structural heart disease and critical care, has acquired Innovalve Bio Medical LTD. (Ramat Gan, Israel), an early-stage... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.